Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)
Alexander M. Menzies(The University of Sydney), Rodabe N. Amaria(The University of Texas MD Anderson Cancer Center), Elisa A. Rozeman(The Netherlands Cancer Institute), Alexander C. Huang(Parker Institute for Cancer Immunotherapy), Michael T. Tetzlaff(The University of Texas MD Anderson Cancer Center), Bart A. van de Wiel(The Netherlands Cancer Institute), Serigne Lo(The University of Sydney), Ahmad A. Tarhini(Moffitt Cancer Center), Elizabeth M. Burton(The University of Texas MD Anderson Cancer Center), Thomas E. Pennington(The University of Sydney), Robyn P.M. Saw(The University of Sydney), Xiaowei Xu(University of Pennsylvania), Giorgos C. Karakousis(University of Pennsylvania), Paolo A. Ascierto(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Andrew J. Spillane(The University of Sydney), Alexander C. J. van Akkooi(The Netherlands Cancer Institute), Michael A. Davies(The University of Texas MD Anderson Cancer Center), Tara C. Mitchell(University of Pennsylvania), Hussein A. Tawbi(The University of Texas MD Anderson Cancer Center), Richard A. Scolyer(The University of Sydney), Jennifer A. Wargo(The University of Texas MD Anderson Cancer Center), Christian U. Blank(The Netherlands Cancer Institute), Georgina V. Long(The University of Sydney)
Cited by 427
Abstract
Related Papers
No related papers found
Powered by citation graph analysis